Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding: A Pilot Randomized Control Trial

Trial Profile

Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding: A Pilot Randomized Control Trial

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs Ulipristal (Primary) ; Tranexamic acid
  • Indications Menorrhagia
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Nov 2017 Planned End Date changed from 1 Jun 2019 to 1 Jul 2019.
    • 15 Nov 2017 Planned primary completion date changed from 1 Feb 2019 to 1 Dec 2018.
    • 15 Nov 2017 Planned initiation date changed from 1 Feb 2017 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top